BioJapan
BioJapan is Asia’s premier partnering event for the international biotechnology industr
Pharmaceuticals
Case Study: PR euroCHEM / SME / Search for Partners in Japan
PR euroCHEM / SME / Search for Partners in Japan
Export to Japan 7: Technical Regulations - Pharmaceuticals
04
NOV
2020
What should you know when entering Pharmaceutical market in J
10:30
- 11:00
Export to Japan 9: Technical Regulations - Quasi-Drugs
20
JAN
2021
Various EU products and services began to enjoy benefits from the EU-Japan Econ
Online Training Series
,
Export
,
Training
,
Pharmaceuticals
,
Cosmetics
,
Export to Japan
,
Webinar
10:30
- 11:00
Quasi drugs
— Latest update: May 2024 — Quasi-drugs are medicines for the purpose of prevention of symptoms and hygiene : they have a weaker effect on the human body than medicines. Some products, such as nutritional drinks, shampoos and hair-growth products, are considered “quasi-drugs”, whereas skincare products that are less effective than “quasi-drugs” are classified as cosmetics.
Report: The Biopharmaceuticals Sector in Japan
This report aims to map out the current state of the biopharmaceuticals market in Japan.
Report: The pharmaceuticals industry in Japan
This report is designed to inform EU SMEs about the evolving structure and development trajectory of the pharmaceuticals industry in Japan.
Vitamins & Supplements
— Latest update: August 2022 —
As of 2022, the Japanese Dietary supplement market accounted for a total of roughly 10 billion euros.
Webinar 101: Biotech Market in Japan
19
SEP
2017
Which opportunities does the Biopharmaceutical market in Japan offer to E
10:30
- 11:30
Webinar 116: The pharmaceuticals industry in Japan
10
APR
2018
What business opportunities currently exist for European SMEs seeking to
10:30
- 11:30
Webinar 145: The Biopharmaceuticals sector in Japan
17
OCT
2019
How can I access the Japanese market as a novel biopharmaceutical product
10:30
- 11:30